Vitamin D3 tablets — Competitive Intelligence Brief

Vitamin D3 tablets (Vitamin D3 tablets) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D supplement / Secosteroid. Area: Nutritional supplementation / Bone health / Immunology.

marketed Vitamin D supplement / Secosteroid Vitamin D receptor (VDR) Nutritional supplementation / Bone health / Immunology Small molecule

Target snapshot

Vitamin D3 tablets (Vitamin D3 tablets) — Ain Shams University. Vitamin D3 acts as a hormone precursor that is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin D3 tablets TARGET	Vitamin D3 tablets	Ain Shams University	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Cholecalciferol (vitamin D)	Cholecalciferol (vitamin D)	University of Tromso	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
D3 vitamin	D3 vitamin	Medical University of Lodz	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D supplement / Secosteroid class)

1. Ain Shams University · 1 drug in this class
2. Medical University of Lodz · 1 drug in this class
3. University of Tromso · 1 drug in this class